Skip to content
1932

Pharmacology

All about cholesterol

The latest science on how blood levels of HDL, LDL and more relate to cardiovascular health

We urgently need data for equitable personalized medicine

OPINION: A massive bias in medical studies toward men of European origin means that genetic variants in understudied populations don’t get the focus they deserve

The remaining frontiers in fighting hepatitis C

A scientist whose work was key to identifying, studying and finding treatments for this life-threatening virus discusses the scientific journey and challenges that persist

Medications for opioid use disorder — MOUD — and adolescents

Treatment with drugs such as buprenorphine, methadone and naltrexone is deemed the gold standard for youth with opioid addictions. Why isn’t it used more often?

How the placebo effect went mainstream

PODCAST: Sloppy by today’s standards, and maybe even back when it was published in 1955, Henry Beecher’s paper paved the way for sounder drug trials and pushed scientists to better understand how we process pain (Season 3, Episode 3)

After Covid-19, can mRNA vaccines help with cancer as well?

The pandemic put the technology, long in development, to the test. Here’s a look at the status of its application to cancer and when it might reach patients.

Hope for haploinsufficiency diseases

Genetic conditions like Dravet syndrome, which causes severe childhood epilepsy, are hard to tackle with traditional gene therapy. New approaches in the works include using antisense therapy to boost mRNA splicing.

Scientific highs and lows of cannabinoids

Hundreds of these cannabis-related chemicals now exist, both natural and synthetic, inspiring researchers in search of medical breakthroughs — and fueling a dangerous trend in recreational use

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error